Infectious Disease In-vitro Diagnostics Market to Reflect Impressive Expansion During 2021 to 2028: Grand View Research Inc.

 Infectious Disease In-vitro Diagnostics Market Growth & Trends

The global infectious disease in-vitro diagnostics market size is expected to reach USD 76.0 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 3.9% from 2021 to 2028. This growth is owing to factors such as the increasing prevalence of infectious diseases, the outbreak of COVID-19, growing market penetration of available treatments, and increasing consumer awareness.

Diagnostics for SARS-CoV-2 detection are being continuously launched for catering to markets that have specific regulatory requirements. For instance, in September 2019, Roche launched its CE Marked antibody diagnostic test Elecsys Anti-SARS-CoV-2 S. Thus, the launch of new diagnostics is expected to lead to an increase in demand owing to their usage in the characterization of the vaccine-induced immune response, thereby boosting vaccine development.

Technological advancements, such as the introduction of portable instruments like Cobas 4800 developed by Roche Diagnostics and GeneXpert by Cepheid are expected to drive market growth over the forecast period. Furthermore, increasing use of these systems to develop new tests that can detect infectious diseases is expected to fuel market growth.

An increase in the prevalence of MRSA infection, high consumer awareness, and the presence of high unmet patient needs are some of the factors expected to drive the market during the forecast period. Diagnosis of MRSA infection involves rapid culture methods and molecular techniques for assessment of MRSA colonization. The presence of a large number of diagnostic tests and the introduction of new products, such as LightCycler, TaqMan, RotorGene, and Stratagene, are expected to propel segment growth.

The launch of new products is becoming a key strategy adopted by players, as new SARS-CoV-2 diagnostics are being launched by major players such as BD, bioMérieux SA, and F. Hoffmann-La Roche Ltd. For instance, in March 2020, Abbott launched the RealTime SARS-CoV-2 assay, a PCR-based test for the diagnosis of COVID-19, and BioMedomics launched a PoC COVID-19 test that can detect antibodies in blood within 15 minutes.

Request a free sample copy or view report summary: Infectious Disease In-vitro Diagnostics Market Report

Infectious Disease In-vitro Diagnostics Market Report Highlights

• The reagents segment dominated the overall market majorly driven by the high usage rate
• The molecular diagnostics technology segment accounted for the highest revenue share in 2020. This can be attributed to the usage of PCR test for Covid-19 diagnosis
• The central laboratories segment accounted for a revenue share of around 60.0% in 2020
• North America accounted for the largest revenue share in 2020, driven by a high disease prevalence, rising consumer awareness, proactive government measures, technological advancements, and improvements in healthcare infrastructure
• The market is price-sensitive, creating rigorous competition among players in terms of manufacturing cost-effective and efficient products

Access Press Release@ https://www.grandviewresearch.com/press-release/global-ivd-infectious-disease-market

Infectious Disease In-vitro Diagnostics Market Segmentation

Grand View Research has segmented the global infectious disease in-vitro diagnostics market based on product, technology, application, end-use, and region:

Infectious Diseases IVD Product Outlook (Revenue, USD Million, 2017 - 2028)

• Instruments
  • MRSA
  • Streptococcus
  • Clostridium Difficile
  • VRE
  • CRE
  • Respiratory Virus
  • Candida
  • TB and Drug-resistant TB
  • Gastro-intestinal Panel Testing
  • Chlamydia
  • Gonorrhea
  • HPV
  • HIV
  • Hepatitis C
  • Hepatitis B
  • Covid-19
  • Others
• Reagents
  • MRSA
  • Streptococcus
  • Clostridium Difficile
  • VRE
  • CRE
  • Respiratory Virus
  • Candida
  • TB and Drug-resistant TB
  • Gastro-intestinal Panel Testing
  • Chlamydia
  • Gonorrhea
  • HPV
  • HIV
  • Hepatitis C
  • Hepatitis B
  • Covid-19
  • Others
• Services
  • MRSA
  • Streptococcus
  • Clostridium Difficile
  • VRE
  • CRE
  • Respiratory Virus
  • Candida
  • TB and Drug-resistant TB
  • Gastro-intestinal Panel Testing
  • Chlamydia
  • Gonorrhea
  • HPV
  • HIV
  • Hepatitis C
  • Hepatitis B
  • Covid-19
  • Others

Infectious Diseases IVD Technology Outlook (Revenue, USD Million, 2017 - 2028)

• Immunoassay
• Molecular Diagnostics
• Microbiology
• Others

Infectious Diseases IVD Application Outlook (Revenue, USD Million, 2017 - 2028)

• MRSA
• Streptococcus
• Clostridium Difficile
• VRE
• CRE
• Respiratory Virus
• Candida
• TB and Drug-resistant TB
• Gastro-intestinal Panel Testing
• Chlamydia
• Gonorrhea
• HPV
• HIV
• Hepatitis C
• Hepatitis B
• Covid-19
• Others

Infectious Diseases IVD End-use Outlook (Revenue, USD Million, 2017 - 2028)

• Point of care
• Central Laboratories
• Others

Infectious Diseases IVD Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • UAE
  • Saudi Arabia

List of Key Players of Infectious Disease In-vitro Diagnostics Market

• BD
• bioMérieux SA
• Abbott
• Quidel Corporation
• OraSure Technologies, Inc.
• Hologic, Inc. (Gen-Probe)
• Danaher
• QIAGEN
• Hoffmann-La Roche, Ltd.
• Siemens Healthineers AG
• Bio-Rad Laboratories, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Viral Vectors And Plasmid DNA Manufacturing Market Poised to Expand at a Robust Pace of USD 8.6 Billion Over 2028: Grand View Research Inc.

 Viral Vectors And Plasmid DNA Manufacturing Market Growth & Trends

The global viral vectors and plasmid DNA manufacturing market size is expected to reach USD 8.6 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 18.8% from 2021 to 2028. The robust pipeline for gene therapies and viral-vector-based vaccines has primarily driven the market.

Amidst the COVID-19 pandemic, the demand for viral vectors has rapidly increased especially in vaccinology. This led to expanding manufacturing capabilities by operating players to meet the growing demand. The application of these vectors in vaccine development has witnessed significant growth in 2020.

Also, an increase in the number of gene therapy-based discovery programs initiated by biotechnology and pharmaceutical companies is expected to drive the demand for scalable production of gene therapy vectors. Owing to this, several private and public agencies are providing funds to accelerate advancements in the manufacturing processes for viral vectors.

Besides, the implementation of single-use technology can lead to significant savings in capital, operating costs, materials, and labor. The use of this equipment will enhance efficiency and improve flexibility, leading to high yields of the final product. Thus, advancements in single-use technology directly impact revenue growth in this space.

Request a free sample copy or view report summary: Viral Vectors And Plasmid DNA Manufacturing Market Report

Viral Vectors And Plasmid DNA Manufacturing Market Report Highlights

• The Adeno Associated Virus (AAV) segment accounted for the significant revenue share in 2020. High usage and promising results in gene therapy clinical trialshave boosted its adoption
• Moreover, several biopharma companies are offering their viral vector platform for the development of AAV-based gene therapy products, thereby driving the segment
• The downstream processing segment dominated the market in terms of revenue share. This can be attributed to the availability of advanced purification products
• Owing to the rising demand for cost-effective and scalable manufacturing processes, companies are involved in the development of the upstream cell culture processes
• This is anticipated to result in the notable growth of the upstream processing segment
• The vaccinology segment dominated the market in terms of revenue share in 2020
• The SARS-COV-2 pandemic has supplemented the use of vectors in this segment
• With the active engagement of the research community in the R&D of advanced therapies, research institutes captured the maximum revenue share in the market
• The initiation of several R&D programs by pharmaceutical and biopharmaceutical companies to combat the COVID-19 crisis would further propel market growth
• A rapidly growing pipeline of advanced therapy products for various cancer types has led to lucrative revenue generation in the cancer segment
• North America maintained its dominance in 2020 owing to the high number of entities engaged in offering products and services for viral vector manufacturing in the U.S.
• Furthermore, the remarkable success of viral vector-based Kymriah, Yescarta, and ZOLGENSMA in the U.S. has also contributed to regional dominance
• In Asia Pacific, the market is projected to witness the fastest growth rate owing to industrialization and clinical transformation of gene therapyin the region
• Companies continue to make focused attempts to expand their manufacturing facilities as well as service portfolio to maintain their market presence

Access Press Release@ https://www.grandviewresearch.com/press-release/global-viral-vector-plasmid-dna-manufacturing-market

Viral Vectors And Plasmid DNA Manufacturing Market Segmentation

Grand View Research has segmented the global viral vectors and plasmid DNA manufacturing market on the basis of vector type, workflow, application, end use, disease, and region:

Viral Vectors & Plasmid DNA Manufacturing Vector Type Outlook (Revenue, USD Million, 2017 - 2028)

• Adeno Associated Virus (AAV)
• Lentivirus
• Adenovirus
• Retrovirus
• Plasmid DNA
• Others

Viral Vectors & Plasmid DNA Manufacturing Workflow Outlook (Revenue, USD Million, 2017 - 2028)

• Upstream Processing
  • Vector Amplification & Expansion
  • Vector Recovery/Harvesting
• Downstream Processing
  • Purification
  • Fill-finish

Viral Vectors & Plasmid DNA Manufacturing Application Outlook (Revenue, USD Million, 2017 - 2028)

• Antisense & RNAi
• Gene Therapy
• Cell Therapy
• Vaccinology
• Research Applications

Viral Vectors & Plasmid DNA Manufacturing End-use Outlook (Revenue, USD Million, 2017 - 2028)

• Pharmaceutical and Biopharmaceutical Companies
• Research Institutes

Viral Vectors & Plasmid DNA Manufacturing Disease Outlook (Revenue, USD Million, 2017 - 2028)

• Cancer
• Genetic Disorders
• Infectious Diseases
• Others

Viral Vectors & Plasmid DNA Manufacturing Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • France
  • Italy
  • Spain
  • UK.
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa
  • Saudi Arabia

List of Key Players of Viral Vectors And Plasmid DNA Manufacturing Market

• Merck KGaA
• Lonza
• FUJIFILM Diosynth Biotechnologies
• Cobra Biologics
• Thermo Fisher Scientific
• Waisman Biomanufacturing
• Genezen laboratories
• YPOSKESI
• Advanced BioScience Laboratories, Inc. (ABL)
• Novasep Holdings S.A.S.
• Orgenesis Biotech Israel Ltd
• Vigene Biosciences Inc.
• General electric company (GE Healthcare)
• pharmaceuticals GMBH
• Batavia Biosciences
• Biovion Oy
• Wuxi Apptec Co Ltd
• VGXI Inc.
• Catalent Inc.
• Miltenyi Biotec GmbH
• SIRION Biotech GmbH
• Virovek Incorporation
• BioNTech IMFS GmbH
• VIVEbiotech S.L.
• Creative Biogene
• Vibalogics BmbH
• Takara Bio Inc.
• Cell and Gene Therapy Catapult Bluebird Bio Inc.
• Addgene Inc.
• Aldevron LLC
• Astellas Pharma Inc.
• BioMarin Pharmaceutical
• RegenxBio, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Chile Radiotherapy Market to Reach Around USD 36.0 Million by 2028

 Chile Radiotherapy Market Growth & Trends

The Chile radiotherapy market size is expected to reach USD 36.0 million by 2028, according to a new study by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.7% from 2021 to 2028. The increasing prevalence of cancer and rising healthcare expenditure are factors expected to propel the growth over the forecast period.

There is a significant gap between the required and installed radiotherapy capacity in Chile. As per a recently published report in the International Journal of Radiation Oncology, Chile had around 41 operative LINACs, which is less than the number required to meet the demand. This provides significant opportunities for growth for the market.

According to the International Agency of Research on Cancer (IARC), the estimated number of new lung cancer cases in Chile was around 4,000 in 2020. The number is expected to reach around 5,500 by 2030. The rising incidence of lung cancer can be attributed to increasing smoking. As per the national health survey, currently, 32.5% of the people in Chile are active smokers. The rising incidence of cancer is expected to drive market growth.

Moreover, companies are adopting strategies that allow them to use their resources to aid in the development of new products and enhance their supply chain. For instance, in August 2020, Siemens Healthcare GmbH announced the acquisition of Varian Medical Systems, Inc. in an all-cash transaction that accounted for USD 16.4 billion. This acquisition may enable the company to offer end-to-end oncology products to address the unmet medical needs of cancer treatment on a global scale.

Chronic adverse effects of radiotherapy occur after months or years of treatment. These effects depend on the total dose of radiotherapy received and the area of treatment. In some regions of the body, radiation treatment can lead to a buildup of body fluids and can cause lymphedema. Radiation exposure to healthy cells in the body can lead to apoptosis, senescence, necrosis, and terminal differentiation of healthy cells, which can lead to death. Radiotherapy weakens the body and can attenuate a body's receptiveness to radiation therapy or surgery. The adverse effects of radiation therapy may restrain market growth.

Request a free sample copy or view report summary: Chile Radiotherapy Market Report

Chile Radiotherapy Market Report Highlights

• In 2020, External Beam Radiation Therapy (EBRT) dominated the market and accounted for the largest revenue share of 86.5%. The high price and high installation base of EBRT equipment is one of the factors for the growth of the segment
• The internal beam radiation therapy segment is expected to witness a lucrative CAGR of 6.9% during the forecast period. The ability to deliver the precise dose, increased patient preference, and cost-effectiveness are some factors driving the segment
• The prostate cancer segment dominated the market and accounted for a share of 24.9% in the market in 2020 and is expected to continue its dominance throughout the forecast period. The high incidence and treatment rate of prostate cancer in Chile are some of the factors contributing to its dominance

Access Press Release@ https://www.grandviewresearch.com/press-release/chile-radiotherapy-market-analysis

Chile Radiotherapy Market Segmentation

Grand View Research has segmented the Chile radiotherapy market based on type and application:

Chile Radiotherapy Type Outlook (Revenue, USD Million, 2016 - 2028)

• External Beam Radiotherapy
• Internal Beam Radiotherapy
• Systemic Radiotherapy

Chile Radiotherapy Application Outlook (Revenue, USD Million, 2016 - 2028)

• Breast Cancer
• Prostate Cancer
• Lung Cancer
• Head and Neck Cancer
• Colorectal Cancer
• Others

List of Key Players of Chile Radiotherapy Market

• Varian Medical Systems, Inc.
• Elekta AB
• Accuray Incorporated
• Becton, Dickinson and Company
• Isoray Medical
• NTP Radioisotopes SOC Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

North America Wheelchair Market Set to Record Exponential Growth by 2028: Grand View Research Inc.

 North America Wheelchair Market Growth & Trends

The North America wheelchair market size is expected to reach USD 1.7 billion by 2028, registering a CAGR of 7.9% over the forecast period, according to a new report by Grand View Research, Inc. This is largely due to an increase in the adoption of advanced, compact, and portable mobility aids on account of the growing target population in the U.S. Rising geriatric population is most likely to create higher demand for mobility products, such as wheelchairs. As per the U.S. Census Bureau, mobility is the most common disability among older Americans. 61 million adults live with a disability in the U.S. out of which, 13.7% have mobility disability with serious difficulty walking or climbing stairs.

Also, in 2016, there were 3.3 million wheelchair users in the U.S., with 1.825 million of those users aged 65 years and above. This number is predicted to grow every year, with an expected 2 million new wheelchair users per year. However, the COVID-19 pandemic exacerbated a global shipping and logistics crisis in early 2020, resulting in container shipping shortages and rising costs, as well as interrupting, and potentially continuing to disrupt global trade. This made it difficult for wheelchair manufacturers to obtain necessary products, components, and raw materials. However, companies are anticipated to restart operations due to the ease of lockdown, which will support market growth in the years to come.

Request a free sample copy or view report summary: North America Wheelchair Market Report

North America Wheelchair Market Report Highlights

• The manual wheelchair product segment dominated the market with the largest revenue share of more than 60% in 2020. This growth can be attributed to the high product demand to its low costs and weight and non-dependability on charging
• The adult category segment accounted for the highest revenue share of over 84% in 2020. This is owing to the fact that adults have a higher rate of spinal injuries, neuromuscular diseases, and trunk/neck weakness than children
• The rehabilitation centers application dominated the market with a revenue share of more than 34% in 2020
• The hospitals application segment is anticipated to register the fastest CAGR over the forecast period due to the rising number of medical emergencies that need the use of wheelchairs
• Canada is projected to register the fastest CAGR of more than 8.5% over the forecast period due to the rising number of startups in the country
• For instance, Braze Mobility, a university of Toronto firm, has developed a set of adjustable blind spot sensors that can be mounted on wheelchairs and scooters to make it easier and safer for people to move around

Access Press Release@ https://www.grandviewresearch.com/press-release/north-america-wheelchair-market-analysis

North America Wheelchair Market Segmentation

Grand View Research has segmented the North America wheelchair market based on product, category type, application, and country:

North America Wheelchair Product Outlook (Revenue, USD Million, 2016 - 2028)

• Manual
• Electric

North America Wheelchair Category Outlook (Revenue, USD Million, 2016 - 2028)

• Adult
• Pediatric

North America Wheelchair Application Outlook (Revenue, USD Million, 2016 - 2028)

• Homecare
• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Rehabilitation Centers

North America Wheelchair Country Outlook (Revenue, USD Million, 2016 - 2028)

• US.
• Canada

List of Key Players of North America Wheelchair Market

• Karman Healthcare, Inc.
• Carex Health Brands, Inc.
• Drive Medical Design & Manufacturing
• Medline Industries, Inc.
• Quantum Rehab
• GF Health Products, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Global Healthcare ERP Market to Reach Around USD 10.3 Billion by 2028: Grand View Research Inc.

 Healthcare ERP Market Growth & Trends

The global healthcare ERP market size is expected to reach USD 10.3 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.6% from 2021 to 2028. Healthcare organizations are under pressure to adopt technological solutions to curb the rising expenditures, ineffective hospital service management, rising workforce shortage, and growing patient population. The rising awareness regarding benefits associated with adopting ERP systems, such as high-quality care delivery solutions, eliminating back-end manual activities, and minimizing operational expenses, contribute to the healthcare enterprise resource planning market growth.

The growing demand for ERP systems from small and medium businesses to enhance business processes and outcomes are driving the market. Seamless access to centralized data from remote locations improves the functioning and data management of the organization. The COVID-19 pandemic exposed the shortcomings of the existing systems adopted by healthcare organizations. During the pandemic, several businesses began adopting ERP systems to automate and digitalize their business processes and streamline their workflows to enhance their productivity and efficiency.

The finance and billing function segment dominated the market in 2020 owing to the growing need to amalgamate the front-end revenue cycle management processes, such as patient access, with back-end activities such as claims management. The inventory and material management segment is expected to grow significantly over the forecast period due to the feature of real-time access to manufacturing and supply chain management. The on-premises deployment segment dominated the market in 2020 due to minimizing costs and ease of access. The cloud deployment segment is expected to grow lucratively over the forecast period owing to the growth of cloud computing and improved accessibility of the internet.

North America dominated the market in 2020 due to rising adoption rates of advanced ERP systems and the emergence of AI-empowered solutions, coupled with infrastructure development. Asia Pacific is expected to register a significant growth rate over the forecast period owing to the emergence of start-ups providing AI-powered ERP systems, growing public and private partnerships to promote healthcare IT infrastructure, and availability of an economical high-skilled workforce.

Request a free sample copy or view report summary: Healthcare ERP Market Report

Healthcare ERP Market Report Highlights

• The healthcare enterprise resource planning market growth can be attributed to the growing digitalization of business processes to streamline workflows
• In terms of function, the finance and billing segment dominated the market in 2020, owing to the need to lower barriers between front-end revenue cycle management processes and back-end activities
• The on-premises deployment segment dominated the market in 2020 owing to the ease-of-access and minimum maintenance cost of ERP solutions
• North America dominated the market in 2020 due to the rise in adoption of advanced ERP systems and the significant presence of market players

Access Press Release@ https://www.grandviewresearch.com/press-release/global-healthcare-erp-market

Healthcare ERP Market Segmentation

Grand View Research has segmented the global healthcare ERP market based on function, deployment, and region:

Healthcare ERP Function Outlook (Revenue, USD Million, 2016 - 2028)

• Inventory and Material Management
• Supply Chain and Logistics Management
• Patient Relationship Management
• Finance and Billing
• Others

Healthcare ERP Deployment Outlook (Revenue, USD Million, 2016 - 2028)

• On-premises
• Cloud

Healthcare ERP Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa
  • UAE

List of Key Players of Healthcare ERP Market

• McKesson Corporation
• Microsoft
• Infor
• Odoo
• SAP
• Oracle
• Epicor Software Corporation
• QAD, Inc.
• Aptean
• Sage Group PLC

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Timber Construction Connectors Market Factors Hindering The Growth Rate, Challenges and Restraints For Business Development 2028

 Timber Construction Connectors Market Growth & Trends

The global timber construction connectors market size is expected to reach USD 2.14 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 13.9% from 2021 to 2028. Increasing trends pertaining to timber-based construction, e    specially for residential structures, are expected to drive the demand for timber construction connectors over the forecast period.

Commercial availability of connectors and fasteners in the retail market, coupled with the availability of varied designs and dimensions for connecting components, is a key factor likely to promote the utilization of connectors in wood construction projects. Moreover, custom fastening products with a variety of metals are expected to support product penetration in the market.

The timber to timber product segment accounted for the largest revenue share in 2020 and is anticipated to maintain its lead in the projected period. Growing demand for wood-based frame structures in residential as well as commercial construction projects is likely to ascend the demand for construction connectors.

Key players are aiming to offer custom fastening materials for timber-based construction. Furthermore, the acquisition of production facilities and increasing investments in material development are other factors considered for increasing the market penetration.

Request a free sample copy or view report summary: Timber Construction Connectors Market Report

Timber Construction Connectors Market Report Highlights

• In North America, the timber to timber product segment dominated the market with a revenue share of over 85.0% in 2020 owing to the large demand for wood-based construction projects, especially in the U.S. and Canada
• The residential application segment accounted for the largest revenue share in 2020 owing to the high acceptance of wood structures in single-family housing units
• Europe emerged as the largest regional market in 2020 with a revenue share of more than 35.0%. The growing demand for wood-frame structures in Germany, Sweden, and France is likely to ascend the demand for products in the projected time
• In the European market, Germany held the largest revenue share in 2020. High penetration of wood-based houses in the country and increasing trends for eco-friendly constructions for commercial projects are the factors governing the market growth
• Manufacturers are aiming to achieve optimum business growth by implementing strategies including acquisition, joint venture, capacity expansion, new product development, promotion of key product brands, and significant investments in R&D

Access Press Release@ https://www.grandviewresearch.com/press-release/global-timber-construction-connectors-market

Timber Construction Connectors Market Segmentation

Grand View Research has segmented the global timber construction connectors market on the basis of product, application, and region:

Timber Construction Connectors Product Outlook (Revenue, USD Million, 2017 - 2028)

• Timber to Timber
• Timber to Masonry
• Timber to Steel

Timber Construction Connectors Application Outlook (Revenue, USD Million, 2017 - 2028)

• Residential
• Commercial
• Infrastructure

Timber Construction Connectors Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Russia
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Southeast Asia
• Central & South America
  • Brazil
  • Argentina
• Middle East & Africa

List of Key Players of Timber Construction Connectors Market

• Pryda (ITW, Inc.)
• Simpson Strong Tie Co., Inc.
• MITEK INC.
• Timberplates
• Connext Post and Beam
• Knapp GmbH
• Eurotec GmbH
• MTC Solutions
• BPC Fixings (The Vista Group)
• Globus Industries
• CQFD
• Taurus India Limited

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

U.S. RTD Organic Tea Market Top Players, Segments, Cost Structure, Demand, Sales | 2028 Forecast

 U.S. RTD Organic Tea Market Growth & Trends

The U.S. RTD organic tea market size is anticipated to reach USD 3.09 billion by 2028, registering a CAGR of 4.4% over the forecast period, according to a new report by Grand View Research, Inc. The growing demand for ready-to-drink (RTD) beverages, owing to consumers’ busy lifestyles and hectic work schedules, is driving the growth of this market. This trend has grown significantly in the U.S. over the past few years, despite - and in many ways because of - the COVID-19 pandemic as consumers are focusing on living a more active lifestyle, which also includes spending more time outdoors. Moreover, the growing number of working individuals is anticipated to drive the demand for convenient RTD beverages, including organic tea.

Millennials and working professionals are becoming increasingly health-conscious and are shifting to healthy foods and drinks. Key players are launching new products that are tasty as well as healthy. For instance, in May 2019, The Granny Squibb Company launched a new range of canned RTD organic teas in three flavors. These product launches are increasing product visibility and driving the demand in the western region of the U.S. Nowadays, consumers are willing to spend more on eco-friendly and convenient food and drink products. RTD organic teas sold in cans are immensely popular among this consumer group as the 100% recyclability of aluminum cans attracts those who are particularly conscious about their environmental footprint.

Studies claim that aluminum cans are less costly to fill and transport and easier to stock and stack as compared to glass bottles, which leads to less breakage. The Southwest region is anticipated to register the fastest CAGR of 5.4% during the forecast period. RTD organic tea is majorly sold through supermarkets and hypermarkets in the Southwest region of the U.S. Key local players are opening new stores to gain maximum customers. For instance, in March 2021, H-E-B Grocery Company, a supermarket chain in Texas, announced to open two new stores in Frisco and Plano, one in each city, by the end of 2022. These market trends are anticipated to boost product sales through supermarkets and hypermarkets distribution channels in the region over the forecast period. 

Request a free sample copy or view report summary: U.S. RTD Organic Tea Market Report

U.S. RTD Organic Tea Market Report Highlights

• The demand for organic tea is estimated to increase at a rapid pace over the coming years due to its multiple health benefits
• Through various studies, it has been found that it helps enhance digestive health by improving the activity of healthy bacteria in the gut. Furthermore, it contains theanine, which reduces anxiety
• The black RTD organic tea type segment accounted for the largest revenue share in 2020 and will expand further at a steady CAGR from 2021 to 2028 retaining the leading position in the market
• New product launches, innovations, and packaging upgradations in relation to organic RTD beverages are some of the strategies adopted by the key players to gain a higher market share
• Southeast is expected to record the fastest growth rate from 2021 to 2028 due to the growing consumption of RTD beverages in states including Illinois and Texas

Access Press Release@ https://www.grandviewresearch.com/press-release/us-rtd-organic-tea-market-analysis

U.S. RTD Organic Tea Market Segmentation

Grand View Research has segmented the U.S. RTD organic tea market on the basis of type, distribution channel, and region:

U.S. RTD Organic Tea Type Outlook (Revenue, USD Million, 2016 - 2028)

• Black
• Green
• Herbal
• Others

U.S. RTD Organic Tea Distribution Channel Outlook (Revenue, USD Million, 2016 - 2028)

• Supermarkets/Hypermarkets
• Convenience Stores
• Online

U.S. RTD Organic Tea Regional Outlook (Revenue, USD Million, 2016 - 2028)

• Southeast
• Northeast
• Midwest
• West
• Southwest

List of Key Players of U.S. RTD Organic Tea Market

• Unilever
• The Coca Cola Company
• AriZona Beverages USA
• Tama Tea
• Numi, Inc.
• ITO EN (North America), Inc.
• Teatulia, PBC
• Harney & Sons Fine Teas
• Guayakí Yerba Mate
• Tejava
• Hain Celestial
• Zevia

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Buccal Drug Delivery Systems Market is Projected to Boost USD 5.9 Billion by 2028: Grand View Research Inc.

 Buccal Drug Delivery Systems Market Growth & Trends

The global buccal drug delivery systems market size is expected to reach USD 5.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 9.2% from 2021 to 2028. Buccal drug delivery systems have gained significant momentum since the last decade. Elimination of first-pass metabolism, quick absorption of the pH-sensitive drug, no interaction with stomach acid, quicker onset of action than any oral dose, minimal side effects, and reduced drug degradation are some of the factors fueling the market growth. Buccal drug delivery has gained large acceptance among geriatric patients and patients having difficulty swallowing.

Leading players like Generex, NovaDel, Biodiversity Sciences International, and Transcept Pharmaceuticals are constantly developing critical drugs like insulin, heparin, morphine, long-lasting pain analgesics, and some anti cardiac drugs into rapid mists, mucoadhesive discs, and lozenges. Commercialization of this research would eventually lead to being a major life savior as it would ensure the faster onset of action and eliminate drug degradation. Despite the increased R&D activity among market players, asteep decline was observed in the sales and revenue gainsdue to the outbreak of the Covid-19 pandemic. Except for covid medications, several other drug markets were majorly hit leading to the dip in the market for buccal drug delivery. However, it is expected to bounce back by 2022.

Request a free sample copy or view report summary: Buccal Drug Delivery Systems Market Report

Buccal Drug Delivery Systems Market Report Highlights

• The buccal tablets and lozenges type segment accounted for the largest revenue share in 2020 due to its wider acceptance among patients
• The smoking cessation application segment held the largest share in 2020. Buccal drug delivery is often the most preferred and effective formulation for treating patients with smoking or nicotine addiction
• The hospital end-user segment captured the largest revenue share in 2020 owing to a large number of admissions of geriatric patients and abundant medication supplies
• North America held the largest revenue share in 2020 due to a large number of leading manufacturers and growing research in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-buccal-drug-delivery-systems-market

Buccal Drug Delivery Systems Market Segmentation

Grand View Research has segmented the global buccal drug delivery systems market on the basis of type, application, end-user, and region:

Buccal Drug Delivery Systems Type Outlook (Revenue, USD Million, 2016 - 2028)

• Sublingual Films
• Buccal Tablets and Lozenges
• Oral Sprays

Buccal Drug Delivery Systems Application Outlook (Revenue, USD Million, 2016 - 2028)

• Pain Management
• Smoking Cessation
• Angina Pectoris
• Others

Buccal Drug Delivery Systems End-user Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Ambulatory Centers
• Others

Buccal Drug Delivery Systems Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
  • Norway
  • Sweden
  • Russia
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Turkey
  • UAE

List of Key Players of Buccal Drug Delivery Systems Market

• Teva Pharmaceutical Industries Ltd.
• Pfizer Inc.
• GlaxoSmithKline plc.
• Indivior Pharmaceuticals
• Generex Biotechnology
• Catalent
• ARx LLC
• BioDelivery Sciences International, Inc.
• Cynapsus Therapeutics Inc. 
• Endo Pharmaceuticals plc

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Rat And Mouse Model Market Revenue Sales to Reach USD 2.9 Billion by 2028: Grand View Research Inc.

 Rat And Mouse Model Market Growth & Trends

The global rat and mouse model market size is anticipated to reach USD 2.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.5% from 2021 to 2028. Recent advancements in the field of genetic engineering including piggyBac technologies, Cas-CLOVER, and CRISPR/Cas9 facilitate researchers to develop immunodeficient rat models which can be used for human cell/tissue regeneration and transplants.

Key companies have leveraged advanced technologies such as machine learning, big data analytics, genome engineering tools, and next-generation sequencing technology to develop mouse and rat models with more human-like microbiomes, immune systems, and genetic backgrounds. For instance, models from the Jackson Laboratory reflect the genetic diversity showcased by the human population.

Market participants are focused to develop novel methods to certify that in vivo and in vitro testing complement each other. In this regard, an increase in the adoption rate of organoid systems has been observed. These systems guide engineering as well as enhance the use and selection of animal models. Moreover, the rise in utilization of mouse model in the analysis of SARS-CoV-2 infection in upper and lower respiratory tract infections drives the global market.

Request a free sample copy or view report summary: Rat And Mouse Model Market Report

Rat And Mouse Model Market Report Highlights

• The outbred model system generated the largest revenue amongst model type as outbred strains are genetically diverse and feature well-characterized, stable genetic variation which accurately reflects the genetic structure of human populations
• Therefore, outbred strains such as the Diversity Outbred (DO) mice are used to analyze the genetic complexity behind cancer, autoimmune disorders, addiction, obesity, heart disease, diabetes, and Alzheimer's disease
• The CRISPR/Cas9 segment is anticipated to witness the fastest CAGR from 2021 to 2028 as CRISPR/Cas9 can target any definite exons for exclusion or inclusion within an mRNA
• Additionally, the use of the CRISPR/Cas9 system to generate the knockout mouse models simplifies the whole process and reduces the timeframe from 1-2 years to 6 months
• The cryopreservation segment is expected to gain significant traction during the forecast period
• The technique provides a fast and reliable procedure for archiving sperm and embryos of valuable mice strains
• Cancer is the largest revenue-generating application segment as the mouse and human genomes are homologous. Thus, it provides a good tool for cancer research as well as for drug discovery
• Pharmaceutical and biotechnology companies dominated the end-use segment in terms of revenue share in 2020. Rat and mice models are some of the most used animal models in drug discovery
• Techniques such as CRISPR/Cas9, homologous recombination, and random transgenesis help the biotech and pharma companies to analyze hypotheses or to generate rat models for human diseases
• Genetically engineered models play a vital role to assess and characterize target identification, disease pathology, and in vivo assessment of new molecular entities
• Profitable opportunities offered by the developing nations and have attracted investments from global companies in the Asia Pacific region
• For instance, in July 2021, ERS Genomics Limited signed a non-exclusive license agreement with Japan SLC. This provided the latter access to CRISPR/Cas9 patent portfolio offered by ERS Genomics
• As Japan SLC offers transgenic, hybrid, congenic, immunodeficient, inbred, and outbred animal models to research organizations; an addition of CRISPR/Cas9 technology will enhance its portfolio for rat and mouse models in Japan

Access Press Release@ https://www.grandviewresearch.com/press-release/global-rat-mouse-model-market

Rat And Mouse Model Market Segmentation

Grand View Research has segmented the global rat and mouse model market based on type, technology, service, application, end-use, and region:

Rat And Mouse Model Type Outlook (Revenue, USD Million, 2018 - 2028)

• Knockout
• Knock-in
• Outbred
• Inbred
• Others

Rat And Mouse Model Technology Outlook (Revenue, USD Million, 2018 - 2028)

• Nuclear transferase
• Microinjection
• Embryonic stem cells
• CRISPR/Cas9
• Other Technologies

Rat And Mouse Model Service Outlook (Revenue, USD Million, 2018 - 2028)

• Cryopreservation
• Breeding
• Rederivation
• Genetic testing
• Quarantine depending
• Others

Rat And Mouse Model Application Outlook (Revenue, USD Million, 2018 - 2028)

• Cardiovascular diseases
• Genetic diseases
• Cancer
• Infectious diseases
  • COVID-19
  • Others
• Transplantation
• Toxicology studies
• Others

Rat And Mouse Model End-use Outlook (Revenue, USD Million, 2018 - 2028)

• Pharmaceutical & biotechnology companies
• Academic and research facilities
• Contract research & manufacturing organizations 

Rat And Mouse Model Regional Outlook (Revenue, USD Million, 2018 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • France
  • UK.
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa
  • Saudi Arabia

List of Key Players of Rat And Mouse Model Market

• Charles River Laboratories International, Inc.
• The Jackson Laboratory
• Laboratory Corporation of America Holdings (Covance)
• Perkin Elmer (Horizon Discovery Group plc)
• genOway
• Envigo
• JANVIER LABS
• Taconic Biosciences, Inc.
• Biomedical Research Models (Biomere)
• Transpogen Biopharmaceutical, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Retail Coolers Market Significant Profits Estimated to be Generated by 2028: Grand View Research Inc.

 Retail Coolers Market Growth & Trends

The global retail coolers market size is expected to reach USD 2.3 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.2% from 2021 to 2028. The growing popularity of outdoor recreational activities such as off-roading and hiking among travelers is a leading factor driving the market.

Rising demand for packaged food and beverages, along with the rapid expansion of the hospitality sector, has led to substantial market growth. The ongoing expansion of consumer goods retail chains across the globe is also likely to drive the market further. A cooler or an icebox presents a great advantage all year round.

In addition, better technologies used for manufacturing lightweight chillers that can retain ice for a longer duration will contribute to market growth over the coming years. It offers the comfort of storage space, particularly while traveling for picnics, long drives, fishing trips, camping, and boating, among many others.

In terms of value, coolers with a capacity of above 50 quarts segment dominated the market, which is expected to account for the largest market share over the forecast period. These large-capacity retail coolers are perfect for long road trips, days spent at campsites, and for sporting events. Additionally, the product is often equipped with heavy-duty wheels to roll the cooler through tough terrain with the rigged wheels while it’s fully loaded.

North America held the largest share in the year 2020, on account of the inclination of people in America towards outdoor recreational activities, short trips, and picnics. According to the prevailing trends, consumers in the U.S. and Canada prefer to travel short distances with hassle-free planning and retail coolers are a convenient option for them.

The COVID-19 outbreak has adversely impacted the demand for retail coolers quite significantly across the globe, especially from the hospitality sector. The closure of non-essential businesses has been one of the major changes to have taken place over the past few months, with the food-service industry being adversely affected.

Request a free sample copy or view report summary: Retail Coolers Market Report

Retail Coolers Market Report Highlights

• The below 10 quarts segment is projected to witness a CAGR of 8.2% over the forecast period
• In terms of distribution channels, the offline segment accounted for the largest revenue share of 83.6% in 2020. However, the online segment is projected to witness the fastest CAGR of 8.2% over the forecast period
• The above 50 quarts segment held the largest revenue share of 54.3% in the year 2020. These retail coolers possess higher ice retention capacity, i.e., up to five days, and can have a capacity of 70 quarts. These large-capacity retail coolers are perfect for long road trips, days spent at campsites, and for sporting events
• North America held the largest revenue share of 38.0% in 2020. The high inclination of people in America towards outdoor recreational activities, short trips, and picnics is fueling the demand for retail coolers in the market

Access Press Release@ https://www.grandviewresearch.com/press-release/global-retail-coolers-market

Retail Coolers Market Segmentation

Grand View Research has segmented the global retail coolers market on the basis of capacity, distribution channel, and region:

Retail Cooler Capacity Outlook (Revenue, USD Million, 2016 - 2028)

• Below 10 quarts
• Between 11 to 25 quarts
• Between 26 to 50 quarts
• Above 50 quarts

Retail Cooler Distribution Channel Outlook (Revenue, USD Million, 2016 - 2028)

• Online
• Offline

Retail Cooler Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
• Europe
  • UK.
  • Germany
• Asia Pacific
  • China
  • Japan
  • Australia
• Central & South America
  • Brazil
• Middle East & Africa (MEA)

List of Key Players of Retail Coolers Market

• Polar Bear Coolers
• Lifoam Industries LLC
• ORCA Coolers, LLC
• Plastilite Corporation
• ICEE Containers Pty Ltd.
• Bison Coolers
• Grizzly Coolers LLC
• Huntington Solutions
• The Coleman Company, Inc.
• YETI Holdings, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.